DailyIQ
|
Sector:TechnologyAll sectors
Last updated 3 minutes ago

ROP·Roper Technologies, Inc.

$.
+. (+.%)
High
$360.72
Open
$352.25
Market Cap
35.28B
52W High
$566.24
Low
$350.71
P. Close
$348.51
P/E
20.58
52W Low
$305.96
Fwd P/E
14.60
DailyIQ Est.
$452.58
Technical Score (1D)
59
BUY
News Sentiment
84
BULLISH
Roche’s recent launch of the cobas HDV, its first fully automated, high‑throughput assay for Hepatitis D, marks a significant expansion of the company’s diagnostics portfolio. The new test is designed to streamline diagnosis and monitoring as emerging HDV therapies begin to reach the market, potentially increasing demand for advanced hepatitis diagnostics. By offering a faster, more scalable solution, Roche could capture a larger share of the growing HDV testing market, which may translate into incremental revenue over the next few trading days. The introduction of cobas HDV also signals Roche’s intent to support the clinical pipeline for HDV treatments, positioning the company as a key partner for new drug developers. Investors should watch for early adoption metrics from laboratories and any statements from Roche regarding expected uptake rates. Additionally, any regulatory filings or approvals for the assay in new regions could accelerate market penetration. Competitors may respond with their own high‑throughput hepatitis tests, so monitoring their product announcements will be important. Finally, keep an eye on Roche’s upcoming earnings release for guidance on diagnostics revenue and any commentary on the commercial performance of the new assay.
Earnings Summary
Roper Technologies, Inc. is a diversified technology company that develops vertical software and technology‑enabled products for sectors such as healthcare, education, and financial services, leveraging a broad distribution network to deliver tailored solutions. The firm’s earnings history over the past four quarters shows a consistent pattern of EPS beats: Q4 2024 earned $4.81 versus an estimate of $4.73, Q1 2025 $4.78 versus $4.74, Q2 2025 $4.87 versus $4.83, Q3 2025 $5.14 versus $5.11, and Q4 2025 $5.21 versus $5.19, with a single miss in Q1 2026 where EPS fell to $5.16 against an estimate of $5.30. Revenue has grown from $1.877 billion in Q4 2024 to $2.017 billion in Q3 2025, but the trend slowed in Q4 2025 and Q1 2026, with actuals of $2.059 billion and $2.095 billion falling short of estimates of $2.101 billion and $2.101 billion, respectively. Historically, Roper has maintained strong earnings momentum while experiencing modest revenue growth, and the company has consistently outperformed analyst forecasts in EPS, though recent revenue misses suggest a potential slowdown. Recent news reports that Goldman Sachs and BMO Capital have cut their price targets to $414 and $393, citing weaker margin outlooks and modest revenue growth, and that analysts are focusing on margin guidance and capital allocation in the upcoming earnings call. Investors should watch for guidance on operating margins, capital‑allocation plans, and any commentary on integration progress or cost‑control initiatives, as these factors will shape the company’s near‑term valuation and earnings trajectory. This pattern underscores the importance of monitoring margin trends.

EPS

EstBeatMiss
$4.66$4.84$5.02$5.20$5.39Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$5.29 - -
Q1'26$5.30$5.16-2.7%
Q4'25$5.19$5.21+0.4%
Q3'25$5.11$5.14+0.6%
Q2'25$4.83$4.87+0.8%
Q1'25$4.74$4.78+0.8%

Revenue

EstBeatMiss
$1.8B$1.9B$2.0B$2.1B$2.2BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$2.1B - -
Q1'26$2.1B$2.1B-0.3%
Q4'25$2.1B$2.1B-2.1%
Q3'25 - $2.0B -
Q2'25 - $1.9B -
Q1'25 - $1.9B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

ROP Stock Snapshot

ROP is currently trading at $360.15, giving Roper Technologies, Inc. a market cap of 35.28B and a P/E ratio of 20.6. Today's range spans $350.71–$360.72, with shares opening at $352.25 and moving up $11.64 (3.3%) from the prior close. DailyIQ's technical score sits at 59/100 (HOLD) with a news sentiment reading of 84/100.

Over the past year ROP has traded between $305.96 and $566.24 - the current price is +17.7% off the 52-week low and -36.4% from the high. 26 analysts cover the stock with a Hold consensus and a mean 12-month target of $445.92 (range $349.78–$550.00), implying upside of +23.8%.

The quality factor scores well for Roper Technologies, Inc. (ROP) even in a HOLD phase - at 35.28B in Technology market cap with a 59/100 technical read (HOLD) and bullish sentiment (84/100), the stock's balance sheet and earnings stability attract defensive allocators who don't need a mixed signal to hold the position. (P/E: 20.6) Price: $360.15 (in the lower half of its 52-week range). Range: $305.96–$566.24.

The 52-week range of $305.96–$566.24 for ROP provides the structural reference that options traders, systematic funds, and discretionary managers all anchor to — and at $360.15 (in the lower half of its 52-week range), the stock sits in a zone where the next 5–10% move will likely define which crowd was right. A HOLD signal at 59/100 and bullish news backdrop (84/100) don't break the tie yet, but they narrow the probability distribution toward the upside.